Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Clinical trial NCT00151879 · COMPLETED

Trial details

NCT number: NCT00151879
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Epilepsies, Partial

Start date: 2005-02-01
Primary completion: 2006-05-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.